Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EasyMix: Biphasic Insulin Aspart 30 vs Insulin Glargine in T2D
NCT01123980Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- May 2010
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2010; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01123980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123980.